Barclays initiates Ralliant stock with Overweight rating, sees recovery ahead

Ralliant Corp. (RAL), recently spun off from Fortive, received an Overweight rating and $60 price target from Barclays, which views the $47.36 stock as being at a cyclical trough poised for a sharp earnings upturn by 2026, largely unpriced by the market despite eight consecutive quarters of organic sales declines. This bullish outlook, bolstered by a new $200 million share buyback authorization, contrasts with more cautious Neutral and Underperform ratings from Seaport Global and BofA, respectively, citing ongoing sales challenges and valuation concerns, though BofA notes potential improvements in specific segments and benefits from global infrastructure investments. The divergent analyst views highlight the company's strategic restructuring and the debate over its recovery trajectory post-spin-off.

Analysis

Ralliant Corp. (RAL), newly independent following its spin-off from Fortive (FTV), presents a classic battleground scenario for investors, underscored by sharply divergent analyst initiations. Barclays has taken a bullish stance, assigning an Overweight rating and a $60 price target, suggesting significant upside from the current $47.36 price. Their thesis posits that Ralliant is at a cyclical trough after eight consecutive quarters of year-over-year organic sales declines, and that a potential earnings upturn in 2026 is not yet reflected in the valuation. This view is supported by a recent Q2 pre-announcement indicating that the period of maximum sales decline may have passed. In contrast, Seaport Global and BofA Securities have initiated with Neutral and Underperform ratings, respectively, citing ongoing sales challenges, weak margins in the Tek division, and valuation concerns. Despite its cautious rating, BofA acknowledges potential tailwinds for Ralliant's sensors business from energy transition investments and anticipates improvements in its Test & Measurement segment by Q2 2025. The company's strategic position is further defined by a newly authorized $200 million share buyback program and a near-term outlook from its former parent, Fortive, which projects flat to slightly down revenue.

Key Decisions for Investors

• Investors with a multi-year horizon and higher risk tolerance could consider the current valuation an attractive entry point, aligning with the Barclays thesis that the stock is at a cyclical low point ahead of a 2026 recovery.
• More cautious investors should weigh the significant execution risk highlighted by Seaport and BofA, focusing on the eight consecutive quarters of organic sales declines and weak divisional margins as near-term headwinds.
• Key performance indicators to monitor for a potential turnaround include stabilization in organic sales figures, margin improvement in the Tek division, and management's deployment of the $200 million share buyback authorization.
• The stock offers portfolio diversification into industrial and energy transition themes outside the AI sector, but requires patience for the recovery narrative to materialize against the backdrop of challenging current fundamentals.